Integral Health Asset Management LLC Sells 300,000 Shares of Fresenius Medical Care AG & Co. KGaA $FMS

Integral Health Asset Management LLC reduced its stake in shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 40.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 450,000 shares of the company’s stock after selling 300,000 shares during the period. Integral Health Asset Management LLC owned approximately 0.08% of Fresenius Medical Care AG & Co. KGaA worth $11,848,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Factory Mutual Insurance Co. purchased a new position in shares of Fresenius Medical Care AG & Co. KGaA during the 3rd quarter valued at about $1,769,000. Pzena Investment Management LLC boosted its stake in Fresenius Medical Care AG & Co. KGaA by 1.0% in the third quarter. Pzena Investment Management LLC now owns 14,816,852 shares of the company’s stock worth $390,128,000 after buying an additional 153,870 shares in the last quarter. Todd Asset Management LLC grew its position in Fresenius Medical Care AG & Co. KGaA by 5.2% during the third quarter. Todd Asset Management LLC now owns 1,303,424 shares of the company’s stock valued at $34,319,000 after acquiring an additional 64,311 shares during the last quarter. Teachers Retirement System of The State of Kentucky grew its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 8.3% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 816,200 shares of the company’s stock valued at $21,491,000 after purchasing an additional 62,700 shares during the last quarter. Finally, Trustmark Bank Trust Department purchased a new position in Fresenius Medical Care AG & Co. KGaA in the 2nd quarter worth $1,027,000. 8.37% of the stock is currently owned by hedge funds and other institutional investors.

Fresenius Medical Care AG & Co. KGaA Stock Up 0.1%

Shares of Fresenius Medical Care AG & Co. KGaA stock opened at $22.77 on Friday. The company has a current ratio of 1.26, a quick ratio of 0.92 and a debt-to-equity ratio of 0.40. Fresenius Medical Care AG & Co. KGaA has a 12-month low of $20.94 and a 12-month high of $30.46. The company has a market cap of $13.20 billion, a P/E ratio of 11.92, a PEG ratio of 2.15 and a beta of 0.91. The company’s fifty day simple moving average is $23.13 and its two-hundred day simple moving average is $24.31.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last posted its earnings results on Tuesday, February 24th. The company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.67 by $0.16. Fresenius Medical Care AG & Co. KGaA had a net margin of 5.03% and a return on equity of 8.73%. The firm had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $4.80 billion. Research analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 1.51 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on FMS shares. Truist Financial set a $28.00 price target on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Monday, January 5th. Erste Group Bank downgraded Fresenius Medical Care AG & Co. KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 5th. Morgan Stanley reissued an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday, January 27th. Weiss Ratings upgraded Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, February 26th. Finally, Wall Street Zen upgraded Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 20th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat, Fresenius Medical Care AG & Co. KGaA presently has a consensus rating of “Reduce” and an average price target of $28.00.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.